Impact of Clinical Pharmacist Running Anticoagulation Clinic in Saudi Arabia
Journal of Clinical Medicine · 07.06.2023 · 12 (12) · 3887
DOI: 10.3390/jcm12123887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.06.2023. Verfasst von Abdulrahman Alshaiban und 8 weiteren Autor:innen. Beteiligte Einrichtung: King Faisal Medical City, Ministry of Health, Abha 62521, Saudi Arabia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University.
Abstract (Originalsprache)
Despite the effectiveness of warfarin in extended anticoagulation, its narrow therapeutic index requires frequent dose adjustments and careful patient monitoring. Thus, we aimed to evaluate the outcomes of clinical pharmacists’ intervention in warfarin therapy management in terms of International Normalized Ratio (INR) control, reduction of bleeding, and hospitalization in a tertiary care hospital. An observational retrospective cohort study was conducted on 96 patients taking warfarin therapy in a clinical pharmacist-led anticoagulation clinic. We observed that 39.6% of patients required dose adjustments at their first and second visits. However, dose adjustments during the third, fourth, and fifth weeks were required at 31.1%, 20.8%, and 4.2%, respectively, to achieve INR levels. We also observed that 36.46% of the patients attained the target INR at baseline, which was increased over the first week to the fifth week to 57.29%, 61.46%, 61.46%, 68.75%, and 85.42%, respectively. No one reported the ADR between the third and fifth weeks. Based on our findings, the study strongly suggests that pharmacists’ interventions can improve the health-related quality of life of patients undergoing warfarin therapy. Thus, competent pharmacy personnel must be a priority in both usual patient care and critical care among primary care networks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King Faisal Medical City, Ministry of Health, Abha 62521, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Al-Fara, Abha 62223, Saudi Arabia.
- Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 16273, Saudi Arabia.
ORCID-Profile: Abdulaziz M Kardam, Mohammad Tarique Imam, Ziyad Saeed Almalki, Md Sayeed Akhtar
Förderung
- King Khalid University
Zitieren
APA
Alshaiban, A., Alavudeen, S. S., Alshahrani, I., Kardam, A. M., Alhasan, I. M., Alasiri, S. A., Imam, M. T., Almalki, Z. S., & Akhtar, M. S. (2023). Impact of Clinical Pharmacist Running Anticoagulation Clinic in Saudi Arabia. Journal of Clinical Medicine, 12(12), 3887. https://doi.org/10.3390/jcm12123887
Vancouver
Alshaiban A, Alavudeen SS, Alshahrani I, Kardam AM, Alhasan IM, Alasiri SA, et al. Impact of Clinical Pharmacist Running Anticoagulation Clinic in Saudi Arabia. Journal of Clinical Medicine. 2023;12(12):3887. doi:10.3390/jcm12123887
BibTeX
@article{Alshaiban2023,
author = {Alshaiban, Abdulrahman and Alavudeen, Sirajudeen S and Alshahrani, Ibrahim and Kardam, Abdulaziz M and Alhasan, Ibrahim Mohammed and Alasiri, Saleh Abdulrahman and Imam, Mohammad Tarique and Almalki, Ziyad Saeed and Akhtar, Md Sayeed},
title = {Impact of Clinical Pharmacist Running Anticoagulation Clinic in Saudi Arabia},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {12},
pages = {3887},
doi = {10.3390/jcm12123887}
}
EUVIMED